Nov 17, 2026
Eloralintide-Peptide.com Breaks Down Lilly's ObesityWeek 2026 EloraTZP Data and the First Participant-Reported Findings on Eloralintide. New analysis separates what changed at ObesityWeek from what did not: responder rates and exit-interview data are new, the headline weight-loss figures are not.
Los Angeles, United States, November 17, 2026 -- Los Angeles, CA – Eloralintide Peptide Research, an independent research resource covering the investigational amylin receptor agonist eloralintide, has published a plain-language breakdown of the data Eli Lilly presented at ObesityWeek 2026 in Washington, DC. The full analysis is available at https://eloralintide-peptide.com/eloralintide-obesityweek-2026/.
Lilly's presentations covered two sets of findings. The first was a group of new responder analyses from the 48-week Phase 2b trial of EloraTZP, the combination of eloralintide and tirzepatide, in 367 adults with obesity or overweight and type 2 diabetes (NCT06603571). The second was the first patient-experience data from the eloralintide Phase 2 monotherapy trial (NCT06230523).
What the new analyses reported
What did not change
The analysis stresses that ObesityWeek produced no new average weight-loss results. The headline figures still come from the September 30, 2026 readout at EASD: 23.3% mean weight loss with eloralintide 9 mg plus tirzepatide 15 mg, against 14.8% with tirzepatide 15 mg alone.
It also flags the limits of the new material. The exit-interview findings are qualitative and self-reported, not trial endpoints. Tolerability remains the open question: 10.8% to 27.0% of participants on the combinations stopped treatment because of side effects, compared with 2.9% on tirzepatide alone. Lilly's Phase 3 program uses a single-injection co-formulation with a slower escalation schedule, and whether that lowers discontinuations will not be known until those trials read out.
"Responder rates make strong headlines, but they are a different cut of the same September data, not a new result," said the editorial team at Eloralintide-Peptide.com. "Our job is to show readers which numbers are new, which are self-reported, and which questions only Phase 3 can answer."
Neither eloralintide nor EloraTZP is approved by the FDA or any other regulator. The site will continue to track the program, including updates analysts expect at Lilly's Innovation Day on December 7, 2026.
Read more articles on eloralintide research, trial data and sourcing, including a look at how the compound is being discussed on reddit.
About Eloralintide Peptide Research
Eloralintide Peptide Research is an independent research resource focused on a single compound. It covers published clinical trials, sourcing checks and certificates of analysis, with figures linked to their original sources. The site is not affiliated with Eli Lilly and Company.
Disclaimer: Content is for research and informational purposes only and is not medical advice. Eloralintide is an investigational compound that has not been approved by the FDA or any other regulator. Clinical trial results describe the investigational drug studied and are not evidence about any vendor's product.
Contact Info:
Name: Benson Jamison
Email: Send Email
Organization: Eloralintide Peptide Research
Phone: 3105613389
Website: https://eloralintide-peptide.com/
Release ID: 89209868
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.
Based on the second of Collins’ two prequel novels, the film is meandering and more than a bit thin, but unlike “The Ballad of Songbirds & Snakes” it’s been directed, by Francis Lawrence, in that lavish mode of surface intensity we might now call Hunger Games Classic.
EXCLUSIVE: Roku is teaming up with LeBron James and Fulwell 73’s Uninterrupted label on a Harlem Globetrotters 100th Anniversary Special, which will celebrate 100 years of the legendary basketball team. The one-hour documentary-style special will feature archival footage and have exclusive behind-the-scenes access to former and current Harlem Globetrotter stars, who will share their experiences […]
A catalog of popular films is being converted into stereo 3D for Meta VR Glasses ahead of the device’s spring 2027 launch, under a new technology partnership between Meta and DNEG, the visual effects and animation company whose slate includes “Ramayana: Rise of a Legend.” DNEG’s Stereo team has already begun work on several of […]
Lamina1 CEO and co-founder Rebecca Barkin has exited her post leading the AI and blockchain-based IP management platform alongside author Neal Stephenson to join live experiences company Tait as chief executive of product and platform technology. In this new role, Barkin will lead the strategy, portfolio direction, and investment priorities for Tait’s technology products and […]
Jordan Firstman and his 10-year-old “Club Kid” co-star Reggie Absolom are headed to the snow (no, not that kind…) in J. Crew’s newest holiday campaign. The new spot, titled “Present Company” launched Nov. 17 and takes inspiration from the retailer’s 1990s catalogs. Photographed by Alasdair McLellan and styled by Miyako Bellizzi, the campaign features Firstman […]
Netflix’s My Next Guest Needs No Introduction With David Letterman will premiere its seventh season on Tuesday, December 15, and a new teaser (above) shares some insight into Letterman’s visits with Matt Damon (Season Premiere, 701), Julia Roberts (Episode 702), Jimmy Kimmel (Episode 703), and professional climber Alex Honnold (Episode 704). The video also gives […]
Not so long ago, the old it’s-funny-because-it’s-true joke about soap operas was that people in soap operas never seemed to watch soap operas. But now that reality shows have all but taken over that space, the function of soaps has evaporated almost entirely, while “unscripted TV” has absorbed all of its clichés. When it first […]
The massive spaces, in Dallas and Philadelphia, feature a new experience themed to the animated smash The post How Netflix House Brought ‘KPop Demon Hunters’ to Life appeared first on TheWrap.
EXCLUSIVE: A daughter’s quest to understand her father leads to surprising revelations in the Oscar-contending documentary Ba’s Book, directed by Ashley Da-Lê Duong. We have your exclusive first look at the film in the trailer above. For Duong, the project began with a decision to travel to Vietnam – against her parents’ wishes – to […]
In this week's Reel to Real column: "Ebenezer" box office, Robert Pattinson as Bond and more The post Is Johnny Depp Back? appeared first on TheWrap.
Our “Popcast” hosts share their reactions across categories.
C4's chief executive is questioned by MPs after a string of allegations were made about the show.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.